Loading AKBA charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AKBA comparable companies…
| AKBAAkebia Therapeutics, Inc.(opens in a new tab) | $0.19B | $0.22B | +7.5% | 79.6% | −6.9% | 0.87× | — |
|---|---|---|---|---|---|---|---|
| VNDAVanda Pharmaceuticals Inc.(opens in a new tab) | $0.23B | $0.23B | +8.1% | 93.6% | −77.6% | 1.00× | — |
| MRVIMaravai Lifesciences Holdings, Inc.(opens in a new tab) | $1.15B | $0.21B | −5.0% | 34.9% | −56.1% | 5.53× | — |
| PBYIPuma Biotechnology, Inc.(opens in a new tab) | $0.55B | $0.23B | −2.9% | 74.8% | 13.2% | 2.37× | 20.1× |
| ANABAnaptysbio, Inc.(opens in a new tab) | $1.39B | $0.23B | +107.7% | — | 17.6% | 5.96× | — |
| Medianpeers, excl. AKBA | $0.85B | $0.23B | +2.6% | 74.8% | −21.5% | 3.95× | 20.1× |